The financials
Bruker Corporation by the numbers
Bruker Corporation (BRKR) reported revenue of $823M in Q1 2026 (quarter ended Mar 31, 2026), up 2.7% from the same quarter a year earlier. That came with a gross margin of 46% and net income of $14M (1.7% of revenue). For the full year FY2025, revenue was $3.44B (+2.1% year on year) and net income −$8.6M. Its largest segment in Jun 2026 was Bsi Calid at $310M, 37% of the disclosed total, just ahead of Bsi Nano at 31%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $823M | $801M | +2.7% |
| Gross profit | $380M | $391M | −2.9% |
| Operating income | $10M | $32M | −68% |
| Net income | $14M | $17M | −17% |
| Diluted EPS | $0.02 | $0.11 | −82% |
| Operating | Revenue | Share |
|---|---|---|
| Bsi Calid | $310M | 37% |
| Bsi Nano | $261M | 31% |
| Bsi Biospin | $196M | 23% |
| Energy And Supercon Technologies | $71M | 8.5% |
Business Segments
Revenue split by operating segment, from SEC XBRL filings.
Latest period: Jun 2026Total $838.5M (+1.8%)
Energy And Supercon Technologies grew +11% year on yearBsi Biospin +0.20% year on year
Segment Latestquarter on quarteryear on year
- Bsi Calid$310.3M$310.3MQoQ -1.9%year on year +8.6%-1.9%+8.6%
- Bsi Nano$261.3M$261.3MQoQ +6.2%year on year +3.6%+6.2%+3.6%
- Bsi Biospin$195.7M$195.7MQoQ -0.91%year on year +0.20%-0.91%+0.20%
- Energy And Supercon Technologies$71.2M$71.2MQoQ +12%year on year +11%+12%+11%
Medical Devices
Ranks #2 of 29 by Smart Score